OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways
Yanan Lv, Xiaona Gao, Yan Luo, et al.
The Journal of Nutritional Biochemistry (2019) Vol. 71, pp. 110-121
Closed Access | Times Cited: 91

Showing 26-50 of 91 citing articles:

The Targeted Impact of Flavones on Obesity-Induced Inflammation and the Potential Synergistic Role in Cancer and the Gut Microbiota
Meenakshi Sudhakaran, Andrea I. Doseff
Molecules (2020) Vol. 25, Iss. 11, pp. 2477-2477
Open Access | Times Cited: 34

Chamomile as a potential remedy for obesity and metabolic syndrome.

EXCLI journal (2021) Vol. 20, pp. 1261-1286
Closed Access | Times Cited: 31

Comparative effects of genistein and bisphenol A on non-alcoholic fatty liver disease in laying hens
Xiaona Gao, Shu‐Hui Liu, Chenchen Ding, et al.
Environmental Pollution (2021) Vol. 288, pp. 117795-117795
Closed Access | Times Cited: 27

Modulatory Properties of Food and Nutraceutical Components Targeting NLRP3 Inflammasome Activation
Mattia Spano, Giacomo Di Matteo, Cinzia Ingallina, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 490-490
Open Access | Times Cited: 20

Apigenin alleviated PA-induced pyroptosis by activating autophagy in hepatocytes
Zhuoqun Meng, Beiwei Zhu, Min Gao, et al.
Food & Function (2022) Vol. 13, Iss. 10, pp. 5559-5570
Closed Access | Times Cited: 20

Extraction optimization, structural characterization and potential alleviation of hyperuricemia by flavone glycosides from celery seeds
Chao Zhang, Ming Zhao, Bei Jiang, et al.
Food & Function (2022) Vol. 13, Iss. 19, pp. 9832-9846
Closed Access | Times Cited: 20

Potential Therapeutic Implication of Herbal Medicine in Mitochondria-Mediated Oxidative Stress-Related Liver Diseases
Moon Nyeo Park, Md. Ataur Rahman, MD. Hasanur Rahman, et al.
Antioxidants (2022) Vol. 11, Iss. 10, pp. 2041-2041
Open Access | Times Cited: 20

Therapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study
Fares E.M. Ali, Islam M. Ibrahim, Osama M Ghogar, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 6, pp. 1026-1053
Open Access | Times Cited: 12

Apigenin inhibits macrophage pyroptosis through regulation of oxidative stress and the NF‐κB pathway and ameliorates atherosclerosis
Xiuzhu Weng, Xing Luo, Xinyu Dai, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 5300-5314
Open Access | Times Cited: 12

Therapeutic potential of bioactive phytoconstituents found in fruits in the treatment of non-alcoholic fatty liver disease: A comprehensive review
Manash Pratim Pathak, Kalyani Pathak, Riya Saikia, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e15347-e15347
Open Access | Times Cited: 11

Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver Diseases
Congjian Shi, Hongqin Yang, Zhenghong Zhang
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 27

CBD Alleviates Liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome–Pyroptosis Pathway
Xuye Jiang, Yingying Gu, Yuanling Huang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26

Apigenin protects mice against 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestasis
Shihong Zheng, Peichang Cao, Zequn Yin, et al.
Food & Function (2021) Vol. 12, Iss. 5, pp. 2323-2334
Closed Access | Times Cited: 24

Ficus hirta Vahl. Ameliorates Nonalcoholic Fatty Liver Disease through Regulating Lipid Metabolism and Gut Microbiota
Ting Quan, Fang-Yu Zhou, Hui-Yuan Chen, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-31
Open Access | Times Cited: 16

Insights into the pharmacological and therapeutic effects of apigenin in liver injuries and diseases
Chenchen Bi, Wenwen Han, Jingru Yu, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15609-e15609
Open Access | Times Cited: 10

Role of apigenin in targeting metabolic syndrome: A systematic review.
Behjat Javadi, Zahra Sobhani
PubMed (2024) Vol. 27, Iss. 5, pp. 524-534
Closed Access | Times Cited: 3

Theobromine ameliorates nonalcoholic fatty liver disease by regulating hepatic lipid metabolism via mTOR signaling pathway in vivo and in vitro
Dan Wei, Shaofei Wu, Jie Liu, et al.
Canadian Journal of Physiology and Pharmacology (2020) Vol. 99, Iss. 8, pp. 775-785
Closed Access | Times Cited: 24

Estrogen Receptor α Regulates Metabolic-Associated Fatty Liver Disease by Targeting NLRP3–GSDMD Axis-Mediated Hepatocyte Pyroptosis
Xiaona Gao, Shuhui Liu, Lei Tan, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 48, pp. 14544-14556
Closed Access | Times Cited: 22

The Role of the Effects of Endoplasmic Reticulum Stress on NLRP3 Inflammasome in Diabetes
Shuangyu Lv, Xiaotian Li, Honggang Wang
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 21

Transcriptomics and proteomics analysis of system-level mechanisms in the liver of apigenin-treated fibrotic rats
Ming Qiao, Jianhua Yang, Yi Zhu, et al.
Life Sciences (2020) Vol. 248, pp. 117475-117475
Closed Access | Times Cited: 23

A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts
Yen‐Chun Koh, Yen-Cheng Lin, Pei‐Sheng Lee, et al.
Food & Function (2020) Vol. 11, Iss. 9, pp. 7545-7560
Closed Access | Times Cited: 21

NOD-like receptors in the pathogenesis of metabolic (dysfunction)-associated fatty liver disease: Therapeutic agents targeting NOD-like receptors
Shaghayegh Khanmohammadi, Bruno Ramos‐Molina, Mohammad Shafi Kuchay
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 7, pp. 102788-102788
Closed Access | Times Cited: 7

Scroll to top